Understanding APS-1
Autoimmune Polyendocrine Syndrome Type 1 (APS-1) is a rare, multisystem disorder characterized by the progressive failure of multiple endocrine glands. This complex condition often begins in childhood and requires a multidisciplinary approach to manage its diverse clinical manifestations.
Our mission at PrimPath is to bridge the gap between clinical research and patient care. By fostering a supportive community and advancing clinical trials, we aim to provide families with the knowledge and resources needed to navigate the challenges of rare autoimmune diseases with confidence and hope.
Diagnosis Process
Initial Screening
Begin with a comprehensive medical history and physical examination to identify early symptoms of autoimmune activity.
Specialized Testing
Utilize advanced laboratory tests, including blood panels and genetic screening, to detect specific markers of APS-1 and rare diseases.
Expert Consultation
Consult with a multidisciplinary team of specialists to interpret complex results and confirm the diagnosis through clinical correlation.
Long-Term Monitoring
Establish a personalized monitoring plan to track disease progression and adjust treatment strategies as needed for optimal health.
Advancing Research
Join our clinical research initiatives to help us understand the complexities of rare autoimmune diseases and accelerate the path to a cure for APS-1.
APS-1 Biomarker Study
A multi-center study investigating genetic markers and immune profiles in early-stage APS-1 patients to identify high-risk individuals.
Therapeutic Trial Phase 2
Evaluating the long-term efficacy of novel immunomodulatory therapies for managing chronic autoimmune symptoms in adults.
Family Support Cohort
Connecting families with clinical resources and providing a structured environment for shared research participation and support.